secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001618835-23-000015
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 2.04, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem receives default notice; Baker Bros. accelerates $92.8M repayment demand
-------------------------------------------------------------------------------

- Baker Bros. Advisors claims Evofem failed to maintain Required Reserve Amount under SPA; demands $92.8M within three business days.
- Evofem disagrees with default claim, invited Designated Agent to rescind notice; exploring all options.
- Default based on Section 9.1(e) of Securities Purchase Agreement dated April 2020; acceleration equal to 2x outstanding plus interest.
- Inadvertent internal disclosure triggered Item 7.01 FD filing; company does not admit materiality.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000015/0001618835-23-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000015/evfm-20230307.htm
  HTML page:      https://secwatch.observer/filing/0001618835-23-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer